Skip to main content
logo

Mankind Pharma Limited (BOM:543904)

India flag India · Delayed Price · Currency is INR
2,458.85
-20.75 (-0.84%)
At close: Oct 10, 2025

Mankind Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212019 - 2020
Period Ending
Oct '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2019 - 2020
Market Capitalization
1,015,3451,000,400921,654---
Upgrade
Market Cap Growth
-4.38%8.54%----
Upgrade
Enterprise Value
1,077,569960,198902,241---
Upgrade
Last Close Price
2458.852422.202296.45---
Upgrade
PE Ratio
53.6450.2548.18---
Upgrade
PS Ratio
7.868.208.98---
Upgrade
PB Ratio
6.976.879.63---
Upgrade
P/TBV Ratio
--12.00---
Upgrade
P/FCF Ratio
-51.2450.17---
Upgrade
P/OCF Ratio
-41.4542.82---
Upgrade
EV/Sales Ratio
8.357.878.79---
Upgrade
EV/EBITDA Ratio
34.4732.1235.87---
Upgrade
EV/EBIT Ratio
43.4939.8941.96---
Upgrade
EV/FCF Ratio
-49.1849.11---
Upgrade
Debt / Equity Ratio
0.580.580.020.020.140.06
Upgrade
Debt / EBITDA Ratio
2.732.840.080.090.440.16
Upgrade
Debt / FCF Ratio
-4.360.110.171.940.34
Upgrade
Asset Turnover
-0.620.950.931.001.09
Upgrade
Inventory Turnover
-2.012.171.841.691.77
Upgrade
Quick Ratio
-0.732.051.140.651.78
Upgrade
Current Ratio
-1.233.102.321.682.89
Upgrade
Return on Equity (ROE)
-16.62%22.57%18.79%25.99%30.30%
Upgrade
Return on Assets (ROA)
-7.58%12.40%10.53%14.76%17.37%
Upgrade
Return on Capital (ROIC)
9.38%9.16%15.29%13.24%18.56%22.22%
Upgrade
Return on Capital Employed (ROCE)
-10.90%21.80%20.20%28.10%31.70%
Upgrade
Earnings Yield
1.86%1.99%2.08%---
Upgrade
FCF Yield
-1.95%1.99%---
Upgrade
Buyback Yield / Dilution
-1.63%-0.88%-0.14%-0.00%--
Upgrade
Total Shareholder Return
-1.59%-0.88%-0.14%-0.00%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.